Home / CHF / Addex Therapeutics GAAP EPS of -CHF 0.15

Addex Therapeutics GAAP EPS of -CHF 0.15

Addex Therapeutics press release (NASDAQ:ADXN): Q1 GAAP EPS of -CHF 0.15. Cash and cash equivalents amounted to CHF 14.9 million as of March 31, 2022, compared to CHF 25.2 million as of March 31 …
Read Full Story at source (may require registration)